Alps ETF Trust · net assets $138M · 92 holdings as of February 28, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 100.0% · STIV: 0.0% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $20.2M | $11.8M | $3.84M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $0 | $1.23M | $5.13M |
| Net realized gain (non-derivative) | $19.1M | $420K | $2.15M |
| Net unrealized appreciation (non-derivative) | $-16.1M | $-263K | $-1.25M |
The three months of the reporting period, as filed; month 3 ends February 28, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Kymera Therapeutics Inc EC | $6.43M | 4.66% |
| Celcuity Inc EC | $4.61M | 3.34% |
| Alkermes PLC EC | $4.43M | 3.21% |
| Cg Oncology Inc EC | $4.23M | 3.06% |
| Mirum Pharmaceuticals Inc EC | $4.23M | 3.06% |
| Amicus Therapeutics Inc EC | $3.95M | 2.86% |
| Acadia Pharmaceuticals Inc EC | $3.7M | 2.68% |
| Newamsterdam Pharma Co Nv EC | $3.58M | 2.60% |
| Crinetics Pharmaceuticals Inc EC | $3.48M | 2.52% |
| Apogee Therapeutics Inc EC | $3.42M | 2.48% |
| Viking Therapeutics Inc EC | $3.41M | 2.47% |
| Structure Therapeutics Inc EC | $3.41M | 2.47% |
| Xenon Pharmaceuticals Inc EC | $2.98M | 2.16% |
| Spyre Therapeutics Inc EC | $2.97M | 2.15% |
| Edgewise Therapeutics Inc EC | $2.87M | 2.08% |
| Tarsus Pharmaceuticals Inc EC | $2.86M | 2.07% |
| Denali Therapeutics Inc EC | $2.78M | 2.01% |
| Ideaya Biosciences Inc EC | $2.52M | 1.82% |
| Travere Therapeutics Inc EC | $2.38M | 1.72% |
| Apellis Pharmaceuticals Inc EC | $2.36M | 1.71% |
| Vera Therapeutics Inc EC | $2.32M | 1.68% |
| Disc Medicine Inc EC | $2.24M | 1.62% |
| Dianthus Therapeutics Inc EC | $2.11M | 1.53% |
| Mineralys Therapeutics Inc EC | $2.06M | 1.50% |
| Galapagos Nv EC | $1.97M | 1.42% |
| Maze Therapeutics Inc EC | $1.96M | 1.42% |
| Zai Lab Ltd EC | $1.92M | 1.39% |
| Stoke Therapeutics Inc EC | $1.85M | 1.34% |
| Nuvation Bio Inc EC | $1.81M | 1.31% |
| Celldex Therapeutics Inc EC | $1.78M | 1.29% |
| Olema Pharmaceuticals Inc EC | $1.7M | 1.23% |
| Pharvaris Nv EC | $1.62M | 1.17% |
| Vericel Corp EC | $1.61M | 1.17% |
| Relay Therapeutics Inc EC | $1.58M | 1.15% |
| Tyra Biosciences Inc EC | $1.58M | 1.15% |
| Agios Pharmaceuticals Inc EC | $1.57M | 1.14% |
| Sarepta Therapeutics Inc EC | $1.57M | 1.13% |
| Oculis Holding Ag EC | $1.5M | 1.09% |
| Amylyx Pharmaceuticals Inc EC | $1.48M | 1.08% |
| Oruka Therapeutics Inc EC | $1.48M | 1.08% |
| Novavax Inc EC | $1.47M | 1.06% |
| Immunocore Holdings PLC EC | $1.45M | 1.05% |
| Sionna Therapeutics Inc EC | $1.45M | 1.05% |
| Palvella Therapeutics Inc EC | $1.42M | 1.03% |
| Mbx Biosciences Inc EC | $1.3M | 0.94% |
| Zenas Biopharma Inc EC | $1.26M | 0.91% |
| Immatics Nv EC | $1.24M | 0.90% |
| Rapport Therapeutics Inc EC | $1.23M | 0.89% |
| Corvus Pharmaceuticals Inc EC | $1.22M | 0.88% |
| Taysha Gene Therapies Inc EC | $1.11M | 0.80% |
| Moonlake Immunotherapeutics EC | $1.11M | 0.80% |
| Day One Biopharmaceuticals Inc EC | $970K | 0.70% |
| Geron Corp EC | $956K | 0.69% |
| Mannkind Corp EC | $898K | 0.65% |
| Compass Therapeutics Inc EC | $896K | 0.65% |
| Arrivent Biopharma Inc EC | $845K | 0.61% |
| Theravance Biopharma Inc EC | $824K | 0.60% |
| Bicara Therapeutics Inc EC | $819K | 0.59% |
| Ars Pharmaceuticals Inc EC | $818K | 0.59% |
| Xencor Inc EC | $813K | 0.59% |
Showing top 60 of 92 holdings.
Loading...
